Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3568
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-08-03T15:39:22Z-
dc.date.available2021-08-03T15:39:22Z-
dc.date.issued2020-08-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3568-
dc.description1 p.-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno IV, n. 40.-
dc.subjectLinfoma não Hodgkinpt_BR
dc.subjectAntineoplásicospt_BR
dc.subjectLymphoma, Non-Hodgkin-
dc.subjectAntineoplastic Agents-
dc.subjectLinfoma no Hodgkinpt_BR
dc.titleLinfoma não Hodgkin difuso de grandes células Bpt_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2020

Files in This Item:
File Description SizeFormat 
informe-sus-onco-agosto-2020_0.pdf447.47 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.